In a pivotal trial of Science’s Prima BCI, 84% of patients impacted by dry AMD were able to read again once fitted with the technology.
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced the appointment of Scott Huennekens as Chairman of its ...
BARCELONA, Spain, December 09, 2025--(BUSINESS WIRE)--INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced ...
INBRAIN Neuroelectronics is gearing up for intelligent brain-computer interface therapeutics by partnering with Microsoft. The company plans to merge its graphene-based neural technology with ...
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...
BARCELONA, Spain, November 10, 2025--(BUSINESS WIRE)--INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced ...
Don't miss out on our latest stories. Add PCMag as a preferred source on Google. Neuralink has a backlog of 10,000 individuals interested in having its N1 device drilled into their skulls, according ...
Don't miss out on our latest stories. Add PCMag as a preferred source on Google. Neuralink has a backlog of 10,000 individuals interested in having its N1 device drilled into their skulls, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results